Cardiac Catheterization, Angiography, IVUS, and FFR

Published on 17/05/2015 by admin

Filed under Internal Medicine

Last modified 17/05/2015

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1934 times

Chapter 14

Cardiac Catheterization, Angiography, IVUS, and FFR

1. What are generally accepted indications for cardiac catheterization?

    Although recommendations are consistently evolving, those listed here are generally accepted as reasonable indications for cardiac catheterization. Cardiac catheterization is a relatively safe procedure; however, life-threatening complications can rarely occur (see later), so there needs to be a clearly thought out and documented indication for catheterization and a plan for how to use the information obtained during catheterization for patient management.

image Class III-IV angina despite medical treatment or intolerance of medical therapy

image High-risk results on noninvasive stress testing

image Sustained (more than 30 seconds) monomorphic ventricular tachycardia or nonsustained (less than 30 seconds) polymorphic ventricular tachycardia

image Sudden cardiac death survivors

image Most patients with non–ST-segment elevation acute coronary syndrome (NSTE-ACS) who have high-risk features and no contraindications to early cardiac catheterization and revascularization

image Systolic dysfunction and stress testing results suggesting multivessel disease and potential benefit from revascularization

image Recurrent typical angina within 9 months of percutaneous coronary revascularization

image For assessment of valvular dysfunction or other hemodynamic assessment when the results of echocardiography are indeterminate

image As part of primary percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI)

image Patients post-STEMI (with or without thrombolytic therapy) with high-risk features, depressed ejection fraction, or high-risk results on subsequent stress testing

image Within 36 hours of STEMI in appropriate patients who develop cardiogenic shock

image In select patients who are to undergo valve replacement or repair

image In assessment and management of patients with congenital heart disease and cardiac transplant recipients

2. What are the risks of cardiac catheterization?

    The risks of cardiac catheterization will depend to some extent on the individual patient. For “all comers,” the risk of death is approximately 1 in 1000, with the risk of myocardial infarction or stroke rarer than 1 in 1000. The risk of any major complication in “all comers” is less than 1%. These risks are summarized in Table 14-1.

TABLE 14-1

RISKS OF CARDIAC CATHETERIZATION AND CORONARY ANGIOGRAPHY

image

Reproduced from David CJ, Bonow RO: Cardiac Catheterization. In Libby P, Bonow RO, Mann DL, Zipes DP, editors: Braunwald’s heart disease: a textbook of cardiovascular medicine, ed 8, Philadelphia, 2007, Saunders, p 461.

3. How are coronary lesions assessed?

    Coronary lesions are most commonly assessed in day-to-day practice based on subjective visual impression (Fig. 14-1). Lesions are subjectively given a percent stenosis, ideally based on ocular assessment of at least two orthogonal images of the lesion. Studies have shown interobserver and intraobserver variability in judging coronary stenosis from as little as 7% to as much as 50%. Quantitative coronary angiography (QCA) more objectively assesses the lesion severity than does “ocular judgment,” but is not commonly used in day-to-day practice. QCA generally grades lesions as less severe than does subjective ocular judgment of a lesion’s severity. Intravascular ultrasound (IVUS) can more accurately assess the total plaque burden and severity of a lesion than can ocular judgment or QCA. Fractional flow reserve (FFR) is increasingly being used to measure the severity of a lesion from a physiologic standpoint (see later).

4. What is considered a “significant” stenosis?

    The classification of significant stenosis depends on the clinical context and what one considers “significant.” Coronary flow reserve (the increase in coronary blood flow in response to agents that lead to microvascular dilation) begins to decrease when a coronary artery stenosis is 50% or more of the luminal diameter. However, basal coronary flow does not begin to decrease until the lesion is 80% to 90% of the luminal diameter.

5. What is fractional flow reserve (FFR)?

    Physiologic assessment of blood flow through a stenotic lesion can be safely and reliably performed in the catheterization laboratory using a coronary wire with a pressure sensor at its tip. The wire is advanced across the lesion of interest, and the ratio of distal coronary pressure to proximal aortic pressure is assessed after maximal hyperemia is achieved (Fig 14-2). This ratio is called FFR. Normal values are close to 1, and a ratio less than 0.75 to 0.80 is taken as indicating a “physiologically significant stenosis.” Adenosine is typically used as a pharmacologic agent to achieve maximal hyperemia.